Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance

The development of infections with ganciclovir (GCV)-resistant human cytomegalovirus (HCMV) remains a serious problem in recipients of stem cell or organ transplants. Nearly all GCV-resistant clinical isolates have mutations in the viral UL97 gene. The rapid detection of GCV-resistant HCMV infection...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antiviral therapy 2008-01, Vol.13 (3), p.461-466
Hauptverfasser: GÖHRING, Katharina, MIKELER, Elfriede, JAHN, Gerhard, ROHDE, Frank, HAMPRECHT, Klaus
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 466
container_issue 3
container_start_page 461
container_title Antiviral therapy
container_volume 13
creator GÖHRING, Katharina
MIKELER, Elfriede
JAHN, Gerhard
ROHDE, Frank
HAMPRECHT, Klaus
description The development of infections with ganciclovir (GCV)-resistant human cytomegalovirus (HCMV) remains a serious problem in recipients of stem cell or organ transplants. Nearly all GCV-resistant clinical isolates have mutations in the viral UL97 gene. The rapid detection of GCV-resistant HCMV infections is necessary and the relative proportions of wild-type and mutant strains are predictive for the efficiency of antiviral therapy. To date, genotypical resistance screening has been limited to restriction fragment length polymorphism (RFLP) and sequencing analyses. Here, we present a comprehensive real-time PCR approach for the detection of most frequent mutations in the UL97 gene associated with GCV resistance. The laboratory strains AD169 and Towne, different wild-type isolates and plasmids constructed by site-directed mutagenesis and overlap extension with specific point-mutations in the UL97 gene were analysed by LightCycler PCR and compared with UL97 RFLP and sequencing analyses. A new and comprehensive set of LightCycler PCRs was created using specific hybridization probes with melting-point analysis for the relevant codons 594, 595, 603 and 607. Different wild-type isolates and plasmids containing specific UL97 mutations conferring GCV resistance were investigated in the real-time PCR assay. Total processing time was 80 min per assay, whereas combinations of RFLP and sequencing needed at least 3-4 days. Proportions of co-existing wild-type and mutant strains in mixed viral populations can be obtained. We established a rapid real-time PCR approach for the detection of most frequent HCMV UL97 mutations associated with GCV resistance. Moreover, the method allows semiquantitative differentiation of the proportions of co-existing wild-type and mutant strains. This approach represents a new alternative for laborious RFLP analysis.
doi_str_mv 10.1177/135965350801300308
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21270068</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21270068</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-1bc950dcca670628b63c58c77709be6f93abe42babbc4f4b969ade7be342cc9f3</originalsourceid><addsrcrecordid>eNplkE9v1DAQRy0EokvhC3BAvsAtMLaTOD6iVfkjrQSq6DmyJ-OtURJvbadSb3x0ErqCA6eRRu_3Do-x1wLeC6H1B6Ea0zaqgQ6EAlDQPWE7CTVUEpruKdttQLURF-xFzj8BZGcAnrML0TVa6hZ27Ne1PYWBZ5rC3WLnEoot4Z54IjtWJUzEv--vuY-Jl1viAxXCEuLMo-e3y2Rnjg8lTnS0Y7wPacn85mA0n5ZNE-fMMc6eUgrzkR_tjAH_cKs-h1zWB71kz7wdM70630t28-nqx_5Ldfj2-ev-46HCWstSCYemgQHRthpa2blWYdOh1hqMo9YbZR3V0lnnsPa1M62xA2lHqpaIxqtL9u7Re0rxbqFc-ilkpHG0M8Ul91JIDdB2KygfQUwx50S-P6Uw2fTQC-i37v3_3dfRm7N9cRMN_ybn0Cvw9gzYjHb0aYuR_3ISlFHGgPoNZS6Nxw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21270068</pqid></control><display><type>article</type><title>Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance</title><source>MEDLINE</source><source>Sage Journals GOLD Open Access 2024</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>GÖHRING, Katharina ; MIKELER, Elfriede ; JAHN, Gerhard ; ROHDE, Frank ; HAMPRECHT, Klaus</creator><creatorcontrib>GÖHRING, Katharina ; MIKELER, Elfriede ; JAHN, Gerhard ; ROHDE, Frank ; HAMPRECHT, Klaus</creatorcontrib><description>The development of infections with ganciclovir (GCV)-resistant human cytomegalovirus (HCMV) remains a serious problem in recipients of stem cell or organ transplants. Nearly all GCV-resistant clinical isolates have mutations in the viral UL97 gene. The rapid detection of GCV-resistant HCMV infections is necessary and the relative proportions of wild-type and mutant strains are predictive for the efficiency of antiviral therapy. To date, genotypical resistance screening has been limited to restriction fragment length polymorphism (RFLP) and sequencing analyses. Here, we present a comprehensive real-time PCR approach for the detection of most frequent mutations in the UL97 gene associated with GCV resistance. The laboratory strains AD169 and Towne, different wild-type isolates and plasmids constructed by site-directed mutagenesis and overlap extension with specific point-mutations in the UL97 gene were analysed by LightCycler PCR and compared with UL97 RFLP and sequencing analyses. A new and comprehensive set of LightCycler PCRs was created using specific hybridization probes with melting-point analysis for the relevant codons 594, 595, 603 and 607. Different wild-type isolates and plasmids containing specific UL97 mutations conferring GCV resistance were investigated in the real-time PCR assay. Total processing time was 80 min per assay, whereas combinations of RFLP and sequencing needed at least 3-4 days. Proportions of co-existing wild-type and mutant strains in mixed viral populations can be obtained. We established a rapid real-time PCR approach for the detection of most frequent HCMV UL97 mutations associated with GCV resistance. Moreover, the method allows semiquantitative differentiation of the proportions of co-existing wild-type and mutant strains. This approach represents a new alternative for laborious RFLP analysis.</description><identifier>ISSN: 1359-6535</identifier><identifier>EISSN: 2040-2058</identifier><identifier>DOI: 10.1177/135965350801300308</identifier><identifier>PMID: 18572760</identifier><language>eng</language><publisher>London: International Medical Press</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Antiviral Agents - pharmacology ; Biological and medical sciences ; Cytomegalovirus - drug effects ; Cytomegalovirus - enzymology ; Cytomegalovirus - genetics ; Drug Resistance, Viral - genetics ; Ganciclovir - pharmacology ; Genotype ; Human cytomegalovirus ; Humans ; Medical sciences ; Mutation ; Pharmacology. Drug treatments ; Phenotype ; Phosphotransferases (Alcohol Group Acceptor) - genetics ; Polymerase Chain Reaction - methods ; Polymorphism, Restriction Fragment Length ; Reproducibility of Results ; Time Factors</subject><ispartof>Antiviral therapy, 2008-01, Vol.13 (3), p.461-466</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-1bc950dcca670628b63c58c77709be6f93abe42babbc4f4b969ade7be342cc9f3</citedby><cites>FETCH-LOGICAL-c472t-1bc950dcca670628b63c58c77709be6f93abe42babbc4f4b969ade7be342cc9f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20393990$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18572760$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GÖHRING, Katharina</creatorcontrib><creatorcontrib>MIKELER, Elfriede</creatorcontrib><creatorcontrib>JAHN, Gerhard</creatorcontrib><creatorcontrib>ROHDE, Frank</creatorcontrib><creatorcontrib>HAMPRECHT, Klaus</creatorcontrib><title>Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance</title><title>Antiviral therapy</title><addtitle>Antivir Ther</addtitle><description>The development of infections with ganciclovir (GCV)-resistant human cytomegalovirus (HCMV) remains a serious problem in recipients of stem cell or organ transplants. Nearly all GCV-resistant clinical isolates have mutations in the viral UL97 gene. The rapid detection of GCV-resistant HCMV infections is necessary and the relative proportions of wild-type and mutant strains are predictive for the efficiency of antiviral therapy. To date, genotypical resistance screening has been limited to restriction fragment length polymorphism (RFLP) and sequencing analyses. Here, we present a comprehensive real-time PCR approach for the detection of most frequent mutations in the UL97 gene associated with GCV resistance. The laboratory strains AD169 and Towne, different wild-type isolates and plasmids constructed by site-directed mutagenesis and overlap extension with specific point-mutations in the UL97 gene were analysed by LightCycler PCR and compared with UL97 RFLP and sequencing analyses. A new and comprehensive set of LightCycler PCRs was created using specific hybridization probes with melting-point analysis for the relevant codons 594, 595, 603 and 607. Different wild-type isolates and plasmids containing specific UL97 mutations conferring GCV resistance were investigated in the real-time PCR assay. Total processing time was 80 min per assay, whereas combinations of RFLP and sequencing needed at least 3-4 days. Proportions of co-existing wild-type and mutant strains in mixed viral populations can be obtained. We established a rapid real-time PCR approach for the detection of most frequent HCMV UL97 mutations associated with GCV resistance. Moreover, the method allows semiquantitative differentiation of the proportions of co-existing wild-type and mutant strains. This approach represents a new alternative for laborious RFLP analysis.</description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cytomegalovirus - drug effects</subject><subject>Cytomegalovirus - enzymology</subject><subject>Cytomegalovirus - genetics</subject><subject>Drug Resistance, Viral - genetics</subject><subject>Ganciclovir - pharmacology</subject><subject>Genotype</subject><subject>Human cytomegalovirus</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Mutation</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenotype</subject><subject>Phosphotransferases (Alcohol Group Acceptor) - genetics</subject><subject>Polymerase Chain Reaction - methods</subject><subject>Polymorphism, Restriction Fragment Length</subject><subject>Reproducibility of Results</subject><subject>Time Factors</subject><issn>1359-6535</issn><issn>2040-2058</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkE9v1DAQRy0EokvhC3BAvsAtMLaTOD6iVfkjrQSq6DmyJ-OtURJvbadSb3x0ErqCA6eRRu_3Do-x1wLeC6H1B6Ea0zaqgQ6EAlDQPWE7CTVUEpruKdttQLURF-xFzj8BZGcAnrML0TVa6hZ27Ne1PYWBZ5rC3WLnEoot4Z54IjtWJUzEv--vuY-Jl1viAxXCEuLMo-e3y2Rnjg8lTnS0Y7wPacn85mA0n5ZNE-fMMc6eUgrzkR_tjAH_cKs-h1zWB71kz7wdM70630t28-nqx_5Ldfj2-ev-46HCWstSCYemgQHRthpa2blWYdOh1hqMo9YbZR3V0lnnsPa1M62xA2lHqpaIxqtL9u7Re0rxbqFc-ilkpHG0M8Ul91JIDdB2KygfQUwx50S-P6Uw2fTQC-i37v3_3dfRm7N9cRMN_ybn0Cvw9gzYjHb0aYuR_3ISlFHGgPoNZS6Nxw</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>GÖHRING, Katharina</creator><creator>MIKELER, Elfriede</creator><creator>JAHN, Gerhard</creator><creator>ROHDE, Frank</creator><creator>HAMPRECHT, Klaus</creator><general>International Medical Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope></search><sort><creationdate>20080101</creationdate><title>Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance</title><author>GÖHRING, Katharina ; MIKELER, Elfriede ; JAHN, Gerhard ; ROHDE, Frank ; HAMPRECHT, Klaus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-1bc950dcca670628b63c58c77709be6f93abe42babbc4f4b969ade7be342cc9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cytomegalovirus - drug effects</topic><topic>Cytomegalovirus - enzymology</topic><topic>Cytomegalovirus - genetics</topic><topic>Drug Resistance, Viral - genetics</topic><topic>Ganciclovir - pharmacology</topic><topic>Genotype</topic><topic>Human cytomegalovirus</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Mutation</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenotype</topic><topic>Phosphotransferases (Alcohol Group Acceptor) - genetics</topic><topic>Polymerase Chain Reaction - methods</topic><topic>Polymorphism, Restriction Fragment Length</topic><topic>Reproducibility of Results</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GÖHRING, Katharina</creatorcontrib><creatorcontrib>MIKELER, Elfriede</creatorcontrib><creatorcontrib>JAHN, Gerhard</creatorcontrib><creatorcontrib>ROHDE, Frank</creatorcontrib><creatorcontrib>HAMPRECHT, Klaus</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Antiviral therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GÖHRING, Katharina</au><au>MIKELER, Elfriede</au><au>JAHN, Gerhard</au><au>ROHDE, Frank</au><au>HAMPRECHT, Klaus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance</atitle><jtitle>Antiviral therapy</jtitle><addtitle>Antivir Ther</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>13</volume><issue>3</issue><spage>461</spage><epage>466</epage><pages>461-466</pages><issn>1359-6535</issn><eissn>2040-2058</eissn><abstract>The development of infections with ganciclovir (GCV)-resistant human cytomegalovirus (HCMV) remains a serious problem in recipients of stem cell or organ transplants. Nearly all GCV-resistant clinical isolates have mutations in the viral UL97 gene. The rapid detection of GCV-resistant HCMV infections is necessary and the relative proportions of wild-type and mutant strains are predictive for the efficiency of antiviral therapy. To date, genotypical resistance screening has been limited to restriction fragment length polymorphism (RFLP) and sequencing analyses. Here, we present a comprehensive real-time PCR approach for the detection of most frequent mutations in the UL97 gene associated with GCV resistance. The laboratory strains AD169 and Towne, different wild-type isolates and plasmids constructed by site-directed mutagenesis and overlap extension with specific point-mutations in the UL97 gene were analysed by LightCycler PCR and compared with UL97 RFLP and sequencing analyses. A new and comprehensive set of LightCycler PCRs was created using specific hybridization probes with melting-point analysis for the relevant codons 594, 595, 603 and 607. Different wild-type isolates and plasmids containing specific UL97 mutations conferring GCV resistance were investigated in the real-time PCR assay. Total processing time was 80 min per assay, whereas combinations of RFLP and sequencing needed at least 3-4 days. Proportions of co-existing wild-type and mutant strains in mixed viral populations can be obtained. We established a rapid real-time PCR approach for the detection of most frequent HCMV UL97 mutations associated with GCV resistance. Moreover, the method allows semiquantitative differentiation of the proportions of co-existing wild-type and mutant strains. This approach represents a new alternative for laborious RFLP analysis.</abstract><cop>London</cop><pub>International Medical Press</pub><pmid>18572760</pmid><doi>10.1177/135965350801300308</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1359-6535
ispartof Antiviral therapy, 2008-01, Vol.13 (3), p.461-466
issn 1359-6535
2040-2058
language eng
recordid cdi_proquest_miscellaneous_21270068
source MEDLINE; Sage Journals GOLD Open Access 2024; EZB-FREE-00999 freely available EZB journals
subjects Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Antiviral Agents - pharmacology
Biological and medical sciences
Cytomegalovirus - drug effects
Cytomegalovirus - enzymology
Cytomegalovirus - genetics
Drug Resistance, Viral - genetics
Ganciclovir - pharmacology
Genotype
Human cytomegalovirus
Humans
Medical sciences
Mutation
Pharmacology. Drug treatments
Phenotype
Phosphotransferases (Alcohol Group Acceptor) - genetics
Polymerase Chain Reaction - methods
Polymorphism, Restriction Fragment Length
Reproducibility of Results
Time Factors
title Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T03%3A08%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rapid%20semiquantitative%20real-time%20PCR%20for%20the%20detection%20of%20human%20cytomegalovirus%20UL97%20mutations%20conferring%20ganciclovir%20resistance&rft.jtitle=Antiviral%20therapy&rft.au=G%C3%96HRING,%20Katharina&rft.date=2008-01-01&rft.volume=13&rft.issue=3&rft.spage=461&rft.epage=466&rft.pages=461-466&rft.issn=1359-6535&rft.eissn=2040-2058&rft_id=info:doi/10.1177/135965350801300308&rft_dat=%3Cproquest_cross%3E21270068%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21270068&rft_id=info:pmid/18572760&rfr_iscdi=true